YL

Yanke Liang

CT C4 Therapeutics: 2 patents #1 of 9Top 15%
DI Dana-Farber Cancer Institute: 2 patents #24 of 217Top 15%
Hoffmann-La Roche: 1 patents #99 of 319Top 35%
TI The Broad Institute: 1 patents #62 of 178Top 35%
The General Hospital: 1 patents #91 of 436Top 25%
📍 Belmont, MA: #8 of 237 inventorsTop 4%
🗺 Massachusetts: #568 of 14,123 inventorsTop 5%
Overall (2021): #25,949 of 548,734Top 5%
5
Patents 2021

Issued Patents 2021

Showing 1–5 of 5 patents

Patent #TitleCo-InventorsDate
11185592 Spirocyclic degronimers for target protein degradation Andrew J. Phillips, Christopher G. Nasveschuk, James A. Henderson, Kiel Lazarski, Ryan E. Michael 2021-11-30
10975058 Imidazolyl kinase inhibitors and uses thereof Nathanael S. Gray, Hwan Geun Choi 2021-04-13
10954242 Bicyclic urea kinase inhibitors and uses thereof Nathanael S. Gray, Hwan Geun Choi, Thomas Sundberg, Alykhan Shamji, Ramnik Xavier +2 more 2021-03-23
10905768 Heterocyclic degronimers for target protein degradation Andrew J. Phillips, Chris G. Nasveschuk, James A. Henderson, Mark Fitzgerald, Minsheng He +1 more 2021-02-02
10882848 2-benzopyrazinyl-n-heteroaryl-2-phenyl-acetamide compounds Martin Duplessis, Georg Jaeschke, Bernd Kuhn, Kiel Lazarski, Yvonne Alice Nagel +3 more 2021-01-05